High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions Ana Teresa MartinsPaula MonteiroCarmen Jerónimo Preclinical study 15 September 2010 Pages: 1 - 9
FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer Hany Onsy HabashyEmad A. RakhaDesmond G. Powe Preclinical study 19 February 2011 Pages: 11 - 21
Effects of estrogen on the proportion of stem cells in the breast Bruno M. SimõesMarco PivaMaria d.M. Vivanco Preclinical study 22 September 2010 Pages: 23 - 35
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis Sean D. McAllisterRyuichi MurasePierre-Yves Desprez Preclinical study 22 September 2010 Pages: 37 - 47
MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements Sebastián GiulianelliJason I. HerschkowitzClaudia Lanari Preclinical study 02 October 2010 Pages: 49 - 67
BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation Takashi IwamotoNoriaki YamamotoShinzaburo Noguchi Preclinical study 30 September 2010 Pages: 69 - 77
The benefits of discussing adjuvant therapies one at a time instead of all at once Brian J. Zikmund-FisherAndrea M. AngottPeter A. Ubel Preclinical study 14 October 2010 Pages: 79 - 87
Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases Jung Min ChangWoo Kyung MoonSeung Ja Kim Clinical trial 17 June 2011 Pages: 89 - 97
Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment Liezel TaylorSarinah BasroKarin Baatjes Clinical Trial 23 June 2011 Pages: 99 - 106
Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial Antonella L. RastelliMarie E. TaylorMatthew J. Ellis Clinical trial 21 June 2011 Pages: 107 - 116
Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer Catherine SchairerLinda M. BrownPhuong L. Mai Epidemiology 09 March 2011 Pages: 117 - 124
Long-term quality of life after breast cancer: a French registry-based controlled study Delphine KleinMariette MercierMichel Velten Epidemiology 22 February 2011 Pages: 125 - 134
Alcohol, tobacco, and mammographic density: a population-based study Anna CabanesRoberto Pastor-BarriusoDDM-Spain Epidemiology 04 March 2011 Pages: 135 - 147
Mouse mammary tumor like virus sequences in breast milk from healthy lactating women Harpreet JohalCaroline FordWilliam Rawlinson Epidemiology 02 March 2011 Pages: 149 - 155
Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy Ingrid E. FakkertLiesbeth JansenGeertruida H. de Bock Epidemiology 04 March 2011 Pages: 157 - 164
Characterizing the impact of 25 years of DCIS treatment Elissa M. OzanneYiwey ShiehLaura J. Esserman Epidemiology 09 March 2011 Pages: 165 - 173
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study Ying LiuRulla M. TamimiGraham A. Colditz Epidemiology 09 March 2011 Pages: 175 - 184
Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women E. ComenM. DavidsM. Robson Epidemiology 11 March 2011 Pages: 185 - 190
The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis Qiang HuangCheng WangJi-Hai Yu Epidemiology 09 March 2011 Pages: 191 - 194
PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China Zhang HuaDalin LiDianjun Li Epidemiology 13 April 2011 Pages: 195 - 201
Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case–control studies Da-Peng DingXiao-Feng HeYing Zhang Epidemiology 22 March 2011 Pages: 203 - 209
Differential expression of prognostic biomarkers between interval and screen-detected breast cancers: does age or family history matter? Jan T. LoweryTim ByersMeenakshi Singh Epidemiology 24 March 2011 Pages: 211 - 219
Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers S. U. DharH. P. CooperS. E. Plon Epidemiology 05 April 2011 Pages: 221 - 227
Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands L. de MunckM. SchaapveldP. H. B. Willemse Epidemiology 24 March 2011 Pages: 229 - 233
Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival Verena VaradiMelanie BevierAsta Försti Epidemiology 01 April 2011 Pages: 235 - 245
Clinical significance of circulating tumor cells in breast cancer patients Min TaoDeliang MaHaiyan Liu Brief Report 22 April 2011 Pages: 247 - 254
Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families Julie JohnsonSue HealeyGeorgia Chenevix-Trench Brief Report 28 April 2011 Pages: 255 - 263
Failure of ovarian ablation with goserelin in a pre-menopausal breast cancer patient resulting in pregnancy: a case report and review of the literature N. HillY. Madarnas Brief Report 04 May 2011 Pages: 265 - 268
The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography Tracy OnegaAndrea CookDiana S. M. Buist Brief Report 07 May 2011 Pages: 269 - 275
XPC gene polymorphisms and breast cancer susceptibility: appraisal of a recent meta-analysis Fang WangYan-Feng ZouGuo-Ping Sun Letter to the Editor 07 April 2011 Pages: 277 - 279
The association between AURKA T91A polymorphism and breast cancer risk Chibo Liu Letter to the Editor 09 April 2011 Pages: 281 - 283
Association between rs3803662 polymorphism of trinucleotide repeat containing 9 gene and breast cancer risk Weidong Chen Letter to the Editor 08 April 2011 Pages: 285 - 286
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study Alexandre Mendonça MunhozRolf GemperliJosé Roberto Filassi Letter to the Editor 16 April 2011 Pages: 287 - 289
Need for clarification of data in the recent meta-analysis about p53 codon 72 polymorphism and breast cancer risk Xiao-Feng HeJiao SuWei Wang Letter to the Editor 20 April 2011 Pages: 291 - 292
Erratum to: Editorial: Cost-effective analyses in Breast Cancer Research and Treatment Marc E. LippmanStephen EthierDaniel F. Hayes Erratum 23 January 2010 Pages: 293 - 293
Erratum to: Postmenopausal estrogen monotherapy–associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk Erratum 08 April 2010 Pages: 295 - 295
Erratum to: Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network Brian CoxRachel Ballard-BarbashDiana Miglioretti Erratum 15 June 2010 Pages: 297 - 298
